DNA helicases use the energy of ATP hydrolysis to disrupt DNA base pairing and displace proteins from DNA in order to facilitate replication, recombination, transcription, and repair. This article focuses on the human RECQ helicases, five DNA-dependent helicases that play key roles in cellular physiology and disease. Loss of function of three RECQ helicases causes the cancer predisposition syndromes Bloom syndrome, Werner syndrome, and Rothmund-Thomson and related syndromes. We summarize recent work on these syndromes and proteins and discuss disease pathogenesis in light of RECQ helicase biochemical activities and in vivo functions.
Introduction
Helicase proteins are ubiquitous enzymes that use the energy of ATP hydrolysis to disrupt DNA or RNA base pairing and promote the unwinding of double-stranded DNA (dsDNA) or RNA duplexes or DNA:RNA hybrid molecules. Helicases can also displace or translocate proteins on DNA and RNA. [1] [2] [3] [4] This article focuses on five members of the human RECQ helicase family, and our understanding of their roles in cellular DNA metabolism and disease. We highlight important recent advances and refer interested readers to other recent reviews that cover these and additional aspects of this rapidly evolving area of human biomedical research.
The RECQ helicase deficiency syndromes
The RECQ helicase deficiency syndromes Bloom syndrome (BS), Werner syndrome (WS), and Rothmund-Thomson (RTS) and related syndromes are rare (#1/50,000 live births), autosomal-recessive Mendelian diseases that share an elevated risk of cancer together with additional features including genetic instability and developmental and disease-specific acquired features. We review key features of the deficiency syndromes to start as these provide a useful focus for thinking about RECQ function and the consequences of loss.
BS is characterized by growth retardation, congenital short stature, and a characteristic sun-sensitive "butterfly" rash across the bridge of the nose and cheeks that may extend to involve the hands and forearms. 5, 6 Many BS patients display both cellular and humoral immune deficits together with an elevated risk of otitis media and pneumonia, an elevated risk of diabetes mellitus, and often reduced fertility. 7 Cancer is the most troubling acquired disease risk and leading cause of death. Cancer risk in BS is unusual in that it encompasses many different tumor types, including common adult epithelial tumors (eg, colon, breast, and lung cancer), leukemias, lymphomas, sarcomas, and a range of embryonal tumors (Wilms' tumor, medulloblastoma, and retinoblastoma). 8 WS alone among the RECQ helicase syndromes has features strongly suggestive of premature aging. Key clinical findings include short stature, early graying and loss of hair, bilateral subcapsular cataracts, and scleroderma-like skin changes. [9] [10] [11] [12] [13] The earliest and most consistent changes are graying and loss of hair beginning with the scalp and eyebrows in the second decade of life, followed by cataract development. The short stature of WS patients is primary -a failure to undergo an adolescent or pubertal growth spurt -rather than the result of an endocrine disturbance. Subcutaneous connective tissue atrophy and dermal fibrosis give skin a "tight, white, and shiny" appearance that with time leads to a progressive sharpening of facial features, foot and ankle deformities with ulceration, and soft tissue calcification. WS patients are at increased risk of atherosclerosis, myocardial infarction and stroke, osteoporosis, and diabetes mellitus. Fertility is reduced in males and females. [9] [10] [11] [12] The central nervous system is typically spared, and WS patients are not at elevated risk of Alzheimer or other types of age-associated dementia apart from those associated with vascular disease.
In contrast to BS, WS confers an elevated risk of only selected types of cancer. [14] [15] [16] [17] The most frequently observed neoplasms are soft tissue sarcomas, follicular thyroid carcinoma, meningioma, acral lentiginous malignant melanoma, malignant or preneoplastic hematologic disease (chiefly leukemias), and osteosarcoma. Cancer and premature cardiovascular disease are the leading causes of death in WS patients. [18] [19] [20] RTS was first described as a familial occurrence of unusual skin changes together with bilateral juvenile cataracts. [21] [22] [23] [24] A characteristic sun-sensitive rash with redness, swelling, and blistering typically appears within the first year of life and may extend to involve the buttocks and extremities while sparing the chest, back, and abdomen. The rash may evolve over time to include variable pigmentation, telangiectasias, and focal atrophy. Hair, eyelashes, and eyebrows are often sparse or absent. Congenital short stature is common, though less severe than in BS. Bone and tooth abnormalities include dysplastic, malformed, or absent bones, often in the hand or thumbs; delayed bone formation or bone density loss; and malformed, missing, or extra teeth. The cataracts originally noted by Rothmund have been documented in only a minority of contemporary RTS patients. 25, 26 Cancer risk is elevated, though largely limited to osteosarcoma. 25, 27, 28 Immunologic function appears to be intact, but fertility may be reduced. Life expectancy in the absence of cancer appears to be normal. 25, 26 Two additional syndromes associated with RECQL4 mutations are RAPADILINO and Baller-Gerold (BGS) syndromes. RAPADILINO syndrome patients have joint dislocations and patellar hypoplasia or aplasia, but lack the skin changes seen in RTS patients. BGS patients have craniosynostosis with radial aplasia in addition to skin changes reminiscent of RTS. 29, 30 
RECQ genes, deleterious mutations, and genomic variants
The genes causally linked to BS, WS, and RTS are members of the human RECQ helicase gene family ( Figure 1 ). 4, 31 BLM was cloned in 1995 by making clever use of the mitotic recombination phenotype of BS cells 32 and led to naming of the family after the helicase domain shared with the 33 and confirmed earlier speculation that the WRN gene might be a helicase. 34 RECQL4 and RECQL5 cloning were based on sequence homology. 35, 36 The remaining family member, RECQL, was identified independently by two groups by virtue of encoding a potent ATPase and helicase activity in human cell extracts. 37, 38 RECQL and RECQL5 have not been linked to human disease though, and as we outline below, there is abundant evidence that heritable loss of function of either has the potential to lead to disease. [39] [40] [41] [42] [43] BLM mutations ascertained in BS patients invariably lead to a loss of helicase function, 44 though do not in all cases eliminate mutant protein expression. In contrast, in WS patients mutations in WRN lead to loss of the WRN protein and both two associated catalytic activities 45, 46 : it appears the loss of both WRN catalytic activities are required to generate WS cellular and clinical phenotypes. 47, 48 Recently reported missense mutations affecting the WRN helicase domain 49 have a high likelihood of destabilizing the mutant protein, as did a previously reported pair of homozygous missense mutations in the exonuclease domain. 18 A surprisingly large number of patients referred with suspected WS lack WRN mutations. 18, 49 Among the subset that fulfill the diagnostic criteria for WS may be individuals with WRN gene silencing, with mutations in proteins required for WRN function, or with novel progeroid syndromes. These patients are prime candidates for targeted exome sequencing.
RECQL4 mutations have been linked to RTS, RAPADILINO, and BGS syndromes. RTS is genetically heterogeneous, with only a portion of clinically ascertained patients having RECQL4 mutations. 26, 27, 29, 30 BGS is also genetically heterogeneous, with subsets of patients having FGFR2 or TWIST mutations. 26 Two other features of clinically ascertained RECQL4 mutations are worth noting. First, an unusually high proportion of recurrent RECQL4 mutations disrupt splicing. This is explained by the genomic structure of the human RECQL4 gene. 50 Second, disease-associated mutations invariably spare the N-terminal portion of the RECQL4 protein. This region shares homology with the yeast replication protein Sld2, which suggests that the Sld2 homology domain of RECQL4 may be essential for DNA replication. 51, 52 All the human RECQ genes have population polymorphic variants of unknown significance in addition to the clearly pathogenic mutations. One WRN polymorphic variant, R834C, has been shown to affect WRN helicase activity, 53 though it does not clearly confer a clinical phenotype resembling WS (A Kamath and L Loeb, personal communication, September 12, 2014) .
RECQ helicase biochemical activities
The enzymatic activities and substrate preferences of the human RECQ helicases have been studied in detail 4,31,54-61 and have been summarized in Table 1 . All the RECQ helicases unwind DNA duplexes with moderate processivity by translocating along one of the strands in 3′-5′ direction while hydrolyzing ATP, and all possess good DNA strand annealing activity. The application of technologies such as single-molecule fluorescence resonance energy transfer and magnetic tweezers 62 have revealed that BLM unwinds a forked partial duplex DNA in repetitive spurts, with a probability of strand reannealing that increases as a function of the length of unwound DNA. 63 Singlestranded DNA binding protein, replication protein A (RPA), etc, stimulates processivity and can shorten the pause between reannealing and the next unwinding cycle. These observations suggest an unwinding model in which BLM switches to the opposite strand of its DNA substrate at the end of the unwinding spurt and translocates by backtracking in a 3′-5′ direction while reannealing single-stranded DNA (ssDNA).
This cycle of unwinding, strand switching, and backtracking with reannealing has been extended by analyses of the activity of two Arabidopsis thaliana RECQ helicases, AtRECQ2 (a WRN homologue) and AtRECQ3 (which may be analogous to human RECQL5), on hairpin substrates. AtRECQ2 activity favors unwinding, whereas AtRECQ3 favors reannealing. 64 These dynamic activities help inform thinking about RECQ helicase actions on biological substrates: cycles of unwinding and reannealing may enable or antagonize specific DNA metabolic processes, while providing opportunities to further regulate RECQ function and the DNA metabolic pathways in which they function. The human RECQ helicases display different activities on in vitro and model physiologic substrates (Table 1) . For example, only BLM and WRN can unwind non-B-form DNAs such as G-quadruplexes (G4), which may correlate with these two RECQ helicases possessing helicase and RNase D C-terminal domains. Likely in vivo genomic targets for this G4-specific activity are G-rich DNAs such as telomeres, ribosomal RNA genes, and G-rich simple sequence repeats and G4 DNA elements in transcribed genes. [65] [66] [67] [68] WRN, BLM, and RECQL can all branch-migrate four-way/ Holliday junctions (HJs); however, only BLM can dissolve these structures in concert with topoisomerase IIIα, RMI1, and RMI2 (the RMI's are both RECQ-Mediated Genome Instability proteins). HJ resolution and dissolution are important in homology-dependent recombination (HR) and DNA replication as we discuss below. WRN can unwind DNA:RNA duplexes, as well as substrates in which one strand has mixed RNA-DNA content similar to that observed in Okazaki fragments. 69 WRN alone among the human RECQ helicases contains a 3′-5′ exonuclease activity, which is active on many of the same substrates that can be unwound by WRN helicase activity. [70] [71] [72] [73] The WRN exonuclease can degrade recessed 3′ ends in dsDNA and initiate DNA degradation from nicks or gaps in dsDNA. 74 Finally, the WRN exonuclease can proofread by excising mismatched 3′ nucleotides in primer/ template substrates. 75 All the human RECQ helicases interact physically and functionally with other DNA metabolic proteins, 4,57,60 and novel interactions continue to be discovered. We touch upon some of the most prominent interactions below when we discuss specific DNA metabolic processes. The RECQ proteins also interact with one another. Examples include the physical and functional interaction of WRN and BLM, with BLM inhibiting the exonuclease activity of WRN, 76 and the functional cooperativity of RECQL and RECQL4 in replication. 43 More recently, RECQL4 has been shown to associate with BLM in vivo and in vitro and stimulate BLM helicase activity on forked DNA substrates. 77 Similar results have been demonstrated for RECQL5 and WRN. 78 
RECQ helicase roles in nucleic acid metabolism
Individual RECQ helicases share common or overlapping roles and may display additional distinct or unique roles in different DNA metabolic processes. We summarize some of the better characterized of these roles below.
DNA double-strand break repair DNA double-strand breaks (DSBs) are potentially lethal lesions that can be generated by exogenous DNA damage (eg, X rays, radiomimetic chemicals, laser-induced strand breaks) as well as by endogenous processes such as immunoglobulin class switching and DNA replication. Cell-based assays have implicated all five RECQs in DSB repair by nonhomologous DNA end joining (NHEJ) or HR. The mechanistic choice between these two options has been a recent focus of intense research, as pathway choice together with activity and fidelity can have a profound impact on genomic stability and cell viability. 79 A key determinant of DSB repair pathway choice is the extent of 5′ DNA end resection to generate recombinogenic 3′-extended ssDNA overhangs. End resection and pathway choice are regulated by the regulatory and enzymatic interplay of ~40 proteins, with prominent regulatory roles for BRCA1, 53BP1, POT1, and RIF1. 80 BLM and WRN can, in conjunction with the multifunctional endonuclease DNA2 or the exonuclease EXO1, promote extensive resection of DSBs [81] [82] [83] after initial short resection initiated by CtIP and the MRE11/ RAD50/NBS1 complex. The specific contribution of these seemingly redundant resection activities is likely to be dictated by the extent of damage, DNA end chemistry, cell cycle phase, and chromatin context. [84] [85] [86] HR-promoting proteins, eg, WRN and BLM in association with the MRE11/RAD50/ NBS1 complex and HR factors BRCA1, RAD51, and EXO1 may compete with NHEJ-promoting proteins such as WRN together with Ku70/80, DNA-PKc, and LigaseIV/XRCC4 to regulate resection. One potential difference between WRN, BLM, and EXO1 is the requirement for CtIP to join long resected ends in BLM-depleted cells. 87 Other contributions of RECQL and WRN to NHEJ are summarized in two recent comprehensive reviews. 4,88 RECQL4 also appears to play a role in NHEJ in conjunction with Ku70/80, by a mechanism yet to be fully elucidated. 89 While the recruitment of RECQL4 to laser-induced DNA breaks has been documented, 90 it is unclear whether this localization has functional significance independent of WRN or BLM.
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duplexes are topologically disentangled and segregated. Likely substrates include D-loop (three-stranded), as well as fourstranded HJ-type recombination products that can be separated by endonuclease cleavage and unwinding or dissolved by topoisomerase-mediated unlinking. The roles of BLM in promoting and suppressing D-loop formation are well understood, as is the unique ability of the BLM 'dissolvasome' consisting of BLM/topoisomerase III∀/RMI1/RMI2 to suppress crossover products from HJ or hemi-catenane substrates. [91] [92] [93] The role of WRN in HJ resolution or D-loop unwinding is well-supported by molecular data, 48, 94 which reflects the strong bias in favor of non-crossover product generation to prevent potentially deleterious genome instability or rearrangement. 92 Finally, RECQL5 may antagonize HR by disrupting RAD51/ ssDNA filament formation to suppress D-loop generation in a manner similar to BLM. 95, 96 The recombination activities of RECQ helicases may have an important subsidiary role in mitotic division by removing physical links between sister chromatids at the end of S-phase (reviewed in Manthei and Keck 93 ). The likely substrates here are catenanes or hemi-catenanes left by fork stall/restart events or at replication termini. Unresolved physical links between sister chromatids can be seen as ultra-fine bridges between chromatids at mitosis. They are prevalent in centromeric and telomeric DNA, and BLM in conjunction with Fanconi Anemia pathway proteins appear to play an important role in ultra-fine bridge resolution prior to mitosis. 97, 98 Ultra-fine bridges are one example of an apparently unique role for BLM. 93 BLM 99 and RECQL5 100 together with topoisomerase II∀ may also play a role in chromatid decatenation prior to mitosis.
Additional repair roles
RECQ helicases appear to function in several other DNA repair pathways. 4 For example, WRN and RECQL4 participate in base excision repair by virtue of physical and/ or functional interactions with APE1 endonuclease, DNA polymerase β, or in the case of WRN with NEIL1, a DNA glycosylase. 4 RECQL5 and RECQL support cellular resistance to oxidative damage 101, 102 as does WRN. RECQL5 may play an additional role in ssDNA break repair and is the only RECQ protein recruited to laser-induced single-strand breaks in vivo. 102 
Global roles in DNA replication
All five of the human RECQ helicase proteins play important roles in DNA replication. RECQ helicases associate with key replication or replication accessory proteins such as DNA polymerases, proliferating cell nuclear antigen, flap endonuclease 1, and RPA. RECQL4, and to a lesser extent RECQL, both bind replication origins and contribute to replication initiation. 43, 103 RECQL4 is found associated with the replication initiation complex via interaction with MCM10 and is required for replication initiation complex assembly (reviewed in Masai 55 ). RECQL4's unique Sld2-like N-terminal DNA-binding domain, 104 may be involved in this specialized function. Given the central role for RECQL4 in DNA replication initiation, it is not surprising that RECQL4-deficient cells have a proliferation defect, elevated DNA damage signaling, and a higher proportion of senescent cells in culture as well as in mouse models reflecting the consequences of disrupted or incomplete DNA replication. 43, [105] [106] [107] Several mouse models of Recql4 deficiency have begun to give information on the lineage-specific consequences of loss of Recql4 function, most notably in maintenance of hematopoiesis. One intriguing aspect of this lineage-specific role is that it does not require the Recql4 helicase activity. 107, 108 The availability to stretch, capture, and visualize individual replicating DNA molecules, a methodology often referred to as DNA fiber stretch or DNA 'combing', has enabled the quantitative analysis of replication dynamics in vivo. DNA fiber data have identified roles for BLM, 109, 110 WRN, 110, 111 and RECQL 43, 112 in replication fork rate maintenance in human cells in culture. Interestingly, the depletion of RECQL5 in WRN-deficient cells severely depresses replication. 78 The mechanistic bases for these global replication roles have not been defined, but Okazaki fragment processing per se is probably not the culprit since loss of flap endonuclease 1 does not slow forks. 113 Less direct effects cannot be ruled out. For example, BLM deficiency can lead to pyrimidine pool imbalances that themselves can independently affect fork rate. 114 These pool imbalances may, in turn, reflect the role of BLM 68 and WRN in regulating gene expression required for S-phase progression (RJM Jr, manuscript in preparation).
Specialized roles in replication -common fragile sites, telomeres, and G4 DNAs RECQ helicases also play important -and potentially critical -roles in the replication of genomic regions that are intrinsically difficult to replicate. Examples include common fragile sites (CFSs), telomeres, and other repeated sequences, in particular those with high G4-forming potential. CFS chromosomal fragility can be exacerbated by suppressing fork progression rates and may reflect an increased probability of fork breakage or fork cleavage 115 2) a paucity of replication initiation sites; and 3) collisions with RNA polymerases that may be actively transcribing or stalled in the large genes found at many CFSs (reviewed in Franchitto 117 ). Without WRN 118 or BLM, 119 CFS fragility is enhanced, whereas RECQL can bind CFSs under conditions of "replication stress" (see below). 103 RECQ helicases also function in telomere replication and maintenance. Telomeric DNA poses a dual challenge to the DNA replication machinery by virtue of the repeated, GC-rich and G4-prone nature of telomeric repeats (TTAGGG in humans), together with the unique chromatin structure formed at chromosome ends. This chromosomal "cap" consists of a telomeric repeat T-loop stabilized by telomere-associated proteins. 120, 121 Moreover, due to the unidirectional nature of fork travel at telomeric ends (centromere . telomere), the G-rich DNA strand is always the lagging strand with ssDNA stretches that may form G4 DNA. Cells lacking any of four RECQ proteins -RECQL, 122 RECQL4, 123 WRN (reviewed in Opresko 124 ), or BLM 98,120 -all show telomere breakage and loss, consistent with the notion that these RECQs help unwind and restructure telomeres to facilitate replication. This was demonstrated at the molecular level for WRN, where its helicase activity was required for complete replication of the G-rich lagging strand of telomeric DNA. 125, 126 A substantial percentage of tumor cells lack telomerase and only gain a measure of replicative immortality by use of a recombination-mediated "alternative lengthening of telomeres" pathway. The alternative lengthening of telomere pathway utilizes HR activities and involves both WRN and BLM (reviewed in Bhattacharyya et al, 127 Mendez-Bermudez et al, 128 and Edwards et al 129 ).
Replication stress -when good forks go bad
A remarkably broad range of chemical, physical, and genetic perturbations can slow or disrupt replication forks to give rise to "replication stress". 130, 131 A common experimental example is to treat cells with the ribonucleotide reductase inhibitor hydroxyurea in order to deplete nucleotide pools and arrest forks. Hydroxyurea-mediated arrest stalls forks globally, though leaves them largely intact and able to resume DNA synthesis (or 'restart') by recruiting or re-engaging DNA polymerases and other proteins including WRN 110,132-135 and BLM. 110, 136 Replication fork maintenance and protection during replication stress, often termed "remodeling", shares many features with the DSB repair pathways discussed above, despite having a different intended goal: to "prevent" fork breakage. Fork remodeling includes RECQ-dependent, reversible DNA strand exchange, and strand resection steps followed by resynthesis (extension). The strand exchanges are from parental-nascent to nascent-nascent strand duplexes and back, leading to fork regression and its reversal ( Figure  2 ). Resection can occur on either duplex. These and other remodeling reactions promote fork persistence by 1) generating ssDNA to activate checkpoint signaling and thus alert the cell to replication blocks; 2) reloading proliferating cell nuclear antigen or related polymerase "clamps"; and 3) recruiting or engaging replicative or specialized DNA polymerases to resume replication or promote lesion bypass.
"Dead end" forks -those that cannot be repaired or remodeled to facilitate restart -can be rescued by endonucleolytic cleavage to generate DNA ends for the DSB repair pathways discussed above. Both the helicase and exonuclease activities of WRN are likely involved, 135 while the BLM dissolvasome may remove topological linkage between sister DNA duplexes generated in the course of strand exchanges. A recent study that combined highresolution molecular and cellular analyses demonstrated that RECQL is specifically required to reverse regressed forks stalled by camptothecin-induced topoisomerase I inhibition. 112 
Mitochondrial DNA maintenance
Among the RECQ helicase proteins, RECQL4 appears to have an important extranuclear role in mitochondrial DNA maintenance. Evidence supporting this idea is the reversible, regulated localization of RECQL4 to the nucleus or cytoplasm 137, 138 ; the interaction of RECQL4 and TP53 protein to promote mitochondrial import of both proteins and their binding to DNA polymerase gamma with modulation of polymerase biochemical activities 139, 140 ; and the accumulation of mitochondrial DNA damage in RECQL4-deficient cells. 141 
DNA transcription
The loss of WRN, BLM, or RECQL function perturbs gene and microRNA (miRNA) expression. Gene expression changes in WRN-and BLM-deficient cells preferentially occur in genes with high G4 DNA-forming potential, thus providing compelling evidence that G4 DNA elements are indeed physiologic substrates for RECQ helicases in living cells. 68, 142, 143 These changes in gene expression are providing new insight into RECQ helicase function and disease pathogenesis (see below). RECQL5, in contrast, was found to slow transcription elongation and limit transcription errors. 40, 59 A final intriguing connection between gene G4-forming potential, replication, and gene expression was revealed by the Sale laboratory (Sarkies et al), 144, 145 in which the presence of G4-forming DNA elements 
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Human ReCQ helicases led to a requirement for WRN or BLM to enable replication and maintain expression-promoting chromatin marks. These results suggest that the absence of RECQ function may further perturb cells by contributing to replication-dependent epigenetic instability. 144, 145 
Regulation of RECQ helicase activities
The regulation of RECQ function through a combination of posttranslational modification, localization, and proteinprotein association is a very active area of research, where we . Each of the four-strand junctions in a double HJ can be resolved, ie, symmetrically cleaved in two ways (marked by arrows) and ligated. One of the cleavage-rejoin options results in crossing over, ie, joining of donor and recipient DNA duplexes (step 5a). A double HJ can also be dissolved by migrating its two branch points toward each other (marked by arrowheads), then using topoisomerase to eliminate the topological linkage between the catenated DNA strands (step 5b). Alternatively, newly synthesized DNA strands can be released from the donor-recipient DNA heteroduplex and anneal with each other to restore DNA integrity, a pathway termed synthesis-dependent strand annealing or SDSA (step 5c). (B) A stalled replication fork can regress, ie, undergo a reversible strand exchange whereby nascent strands pair with each to form a forked structure termed a "chicken foot" (steps 1-2). Alternatively, a nascent strand duplex can be resected (similar to step 2 in DSB repair) to generate a free 3′ single-stranded DNA end 
Posttranslational modification
The RECQ helicase proteins are subject to several different types of posttranslational modifications that govern activity, localization, and protein-protein association. The most extensively developed lines of mechanistic evidence are summarized below and discussed in greater detail elsewhere (eg, Croteau et al 4 ).
Phosphorylation
The ATM and ATR kinases, key components of the response to DNA damage and replication stress, respectively, phosphorylate six S/TQ residues in WRN. WRN phosphorylation by ATR on residues S991, T1152, and S1256 promotes the retention of WRN at stalled forks to preserve their ability to restart replication (see above). Prolonged fork arrest results in MUS81-dependent cleavage 132, 135 to generate DSB ends that trigger ATM-dependent WRN phosphorylation on residues S1058, S1141, and S1292. These alternative phospho-states may facilitate the switch from a replicative to DSB repair mode, with dissociation of WRN from DSB sites. 134, 135, 146 WRN is also phosphorylated by DNA-PK cs and ABL tyrosine kinase, acetylated, and can be associated with SUMO-1, providing additional opportunities for regulation.
SUMOylation
BLM undergoes both constitutive and conditional phosphorylation. These changes are likely to play a role in the targeting and activation of BLM in response to DNA damage, replication stress, and mitotic cycling (reviewed in Böhm and Bernstein 147 ). The modification of BLM residues K317 and K331 by SUMO (sumoylation) after prolonged, DSB-inducing fork arrest may switch BLM from DSB avoidance to a DSB repair mode. 148, 149 This switch may be mediated via decreased association of sumoylated BLM with RPA, together with increased binding to RAD51. 150 Finally, ubiquitylation of BLM appears to play a role in both the response to replication stress and nuclear partitioning. 151 Poly(ADP-ribose) polymerase 1 and poly(ADP-ribose)
Another important example of the regulation of RECQ protein-protein association and functional regulation involves poly(ADP-ribose) polymerase (PARP)-1. PARP-1 is a major PARP in human cells that was initially implicated in base excision repair and single strand break repair but is now known to be involved in virtually every DNA repair pathway as well as in replication stress response and checkpoint signaling. This central role for PARP-1 also suggests it may be an important target in cancer chemotherapy. 152 The current model for PARP-1 function in DNA repair has it acting as a "first responder" to DNA breaks and lesions, where it binds discontinuities in the phosphate backbone of DNA to trigger auto-and trans-PARylation. Poly(ADP-ribose) (PAR) groups on PARP-1 and other proteins then serve to recruit additional signaling and repair proteins which bind PAR groups via several types of PAR recognition motifs. An interesting exception to this widely accepted general model are the RECQ proteins. RECQ helicases do not appear to be substrates of PARP-1 or be recruited by PARylated PARP-1 to DNA. 101, 153 Instead, WRN was shown to bind free PAR (which is cleaved off PARP-1 and targets by PARG) via a newly identified PAR-binding motif in the WRN exonuclease domain. 154 This may dissociate WRN and enable downregulating the DNA damage response. In contrast, WRN and RECQL physically associate with PARP-1 in the absence of DNA. 112, 153, 155 There are also data from mice that the productive interaction of Wrn and Parp-1 is genome stabilizing and can antagonize both karyotypic rearrangements and cancer. 156 While these associations have been well-documented, functional consequences of WRN binding to PARP-1 remain a matter of debate. 153, 157 A better understood example is RECQL association with PARP-1. This association is enhanced by camptothecin (CPT)-induced PARylation of PARP-1 112 and inhibits the ability of RECQL to reverse regressed replication forks in vitro. This fits well with the observed behavior of replication forks in CPT-treated, RECQL-depleted cells treated with PARP inhibitors. 112 Further research will be required to integrate this mechanistically elegant story into a broader context of PARP-1 function in replication and in repair.
Global levels of PARylation in response to oxidative damage have been investigated in WS cells and in WRN-, RECQL-, and RECQL5-depleted cells. These analyses found a less consistent downregulation of PARylation in WRN-depleted cells than was initially observed in WS cells. 155 Subsequent analyses of WRN-depleted cells showed variable, weak effects. RECQL5 and RECQL-depleted cells showed, respectively, constitutive or damage-induced hyperactivation of PARylation, 101, 102 which supports their roles in single strand break repair and base excision repair.
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Human ReCQ helicases Acetylation Two of the human RECQ helicases, WRN and RECQL4, have been shown to be acetylated. In the case of WRN, acetylation appears to modulate both catalytic activity and localization. 158, 159 The histone acetyltransferase p300 acetylates RECQL4 at up to five different lysine residues contained in a 30-residue stretch of RECQL4 that is required for nuclear localization. RECQL4 acetylation by p300 disrupts nuclear import and leads to the cytoplasmic accumulation of RECQL4. 137 There are undoubtedly other posttranslational modifications of RECQ helicase proteins in addition to the few that have been cataloged above. It should be possible to catalog these using both mass spectrometry-based analytical approaches and tie specific modifications to biological activities by the use of a combination of conditional mutant proteins in conjunction with high-resolution functional assays.
From biochemistry to phenotype
The sections above emphasize both the diverse roles of RECQ helicases in DNA metabolism, and the absence of a simple one-to-one mapping of individual RECQ helicases to specific pathways or processes. The human RECQ deficiency syndromes further emphasize that despite their biochemical similarities, the human RECQ helicases are not functionally interchangeable in cells. A focus for research in the immediate future is to elucidate the details of molecular cooperativity and functional redundancy, while identifying potentially unique in vivo roles of each human RECQ helicase.
The human RECQ helicases are ubiquitously expressed in most or all cell lineages. Thus, the consequences of loss of RECQ function -reduced cell proliferation, DNA damage sensitivity, genetic or genomic instability, and altered gene expression -have the potential to disrupt organismal DNA metabolism both during and after development. The biochemical properties and DNA metabolic functions of the human RECQ helicases discussed above provide mechanistic insight into the origins of these cellular phenotypes and serve as the basis for a conceptual model to link molecular and cellular defects to the pathogenesis of the RECQ helicase deficiency syndromes (Figure 3) . WRN-deficient cells display a proliferative defect that reflects a combination of cell cycle abnormalities with longer cell cycle times, especially in response to DNA damage, a reduced growth fraction, and high levels of cellular senescence. 110, 111, 160, 161 Similar defects have been observed in BLMdeficient cells, where the depletion of BLM has a stronger growth-suppressive effect than comparable levels of depletion of WRN. 162, 163 Human cells depleted of RECQL and RECQL4 also display reduced proliferation in culture. 39, 43 These proliferative defects provide a partial explanation for why BS and RTS patients are typically born small, though they are proportionately developed. This is particularly striking in BS patients, who are born and typically remain at or below the fifth percentile for height and weight. 164 DNA replication defects in BS and RTS may lead directly to this organismal phenotype by reducing the number of cells required for development that as a process is otherwise largely normal. The proliferative defects that accompany BLM or RECQL4 loss are more marked than for WRN, which may explain the lack of a strong developmental component as part of the WS clinical phenotype.
The progressive development of progeroid features in WS may reflect postdevelopmental roles for WRN in tissue maintenance. Disrupted DNA metabolism in the absence of WRN may lead to persistent DNA damage signaling and genetic instability with the accumulation of mutant and senescent cells. 161, 165 This progressive accumulation of underperforming cells could further compromise tissue structure and function if accompanied by a local and/or systemic senescent cell-associated secretory phenotype. 166 The age-dependent accumulation of senescent cells has been documented in aging primates, 167, 168 and one testable prediction of our model is that senescent cells are present at elevated levels in WS patients and perhaps in BS and RTS patients.
A second ominous consequence of persistent genetic instability, epigenetic drift, and cell loss is the potential for the emergence of cancer. Cellular senescence in the RECQ helicase syndromes may have one modest silver lining: senescence is an effective, albeit nonspecific, tumorsuppressive mechanism, even in the face of persistent genetic instability. 165, 169 A systematic comparison of genetic and epigenetic alterations in tumors common to WS, BS, and RTS such as osteosarcoma, or unique to one of the syndromes such as acral lentiginous melanoma in WS, might identify mutations or pathways that promote specific neoplasms in RECQ-deficient individuals.
Cells are not passive bystanders when DNA metabolism is disrupted, and as noted above, persistent DNA damage signaling is likely to be an important driver of RECQ cellular phenotypes. An unresolved question is the extent to which disease pathogenesis is driven by RECQ-dependent DNA metabolic defects as opposed to damage signaling or other potentially adaptive responses. We have begun to address this question by quantifying gene and miRNA expression Advances in Genomics and Genetics downloaded from https://www.dovepress.com/ by 54.70.40.11 on 22-Sep-2019 For personal use only.
28 Sidorova and Monnat in BS and WS patient cells and contrasting these changes with comparable profiling data from fibroblasts depleted of WRN or BLM. These analyses have already revealed several intriguing general conclusions: 1) the expression of many (.1,000) genes and dozens of miRNAs is reproducibly altered when WRN or BLM function is lost by mutation or depletion; 2) many of these RECQ-dependent gene expression changes are strongly correlated with the presence of G4 DNA elements in the 5′-end of the altered genes; 3) genes whose expression is altered by WRN or BLM deletion are enriched in DNA metabolic pathways in which RECQ helicases participate; and 4) genes and miRNAs whose expression is altered in WS and/or BS patient cells are strongly enriched for fundamental molecular and cellular processes such as cell growth, proliferation, death, or survival, together with canonical pathways that promote tumorigenesis or tumor type-specific signaling (Nguyen et al 68 These results begin to provide a nuanced view of how RECQ loss alters DNA metabolism, signaling, and gene expression, changes that over time lead to a constellation of broadly adaptive gene and miRNA expression changes that themselves promote the pathogenesis of acquired diseases including cancer.
Broader roles for RECQ helicases in human disease?
An important unanswered question is what role RECQ helicases play in diseases outside of the WS-, BS-, and RTS-deficiency syndromes. Carriers for the recessive RECQ helicase deficiency syndromes are prevalent in the general population: for example, WRN mutation carriers have an estimated frequency of 1/250 in the US population, and there are ~1.5×10 6 mutation carriers in the US population alone. Individuals in WS pedigrees who are heterozygous for pathogenic WRN mutations have in vivo genetic instability, 170 and cell lines from these individuals show intermediate sensitivity to killing by DNA-damaging chemotherapeutic agents that selectively kill WRN-deficient cells. 171, 172 Given their frequency and large number, an important question is whether WRN mutation carriers are at elevated risk of cancer, therapy-related toxicity, or other diseases.
RECQ somatic mutations also have the potential to contribute to disease, though they have been infrequently reported in human tumors. One supposition is that RECQ mutations that lead to loss of function are actively selected against early in tumor progression. Loss, silencing, or altered expression of RECQ genes, in contrast, may be frequent in many tumor types including common adult epithelial cancers such as breast and colorectal cancer. 173 Promoter region and gene body methylation have been suggested as one cause for loss of WRN expression in human tumors. [174] [175] [176] However, the relationship between methylation and loss of expression does not appear to be consistent enough in our and in others' hands to be useful alone as a surrogate expression marker (Bosch et al, unpublished results). Identifying RECQ expression loss in tumors is practically important, as the level of expression may be a useful therapeutic biomarker of drug sensitivity. 163 The RECQ helicase proteins themselves may be direct targets for the treatment of cancer or other diseases. The helicase and, in the case of WRN the exonuclease, catalytic activities of the human RECQ helicases provide ready targets for newly identified small-molecule inhibitors. 3, 177, 178 The direct targeting of tumors with RECQ helicase inhibitors might, in addition, provide a clear, tumor-specific therapeutic advantage if combined with conventional chemotherapy. 3 The targeting of survival pathways specific to one -or common to several -RECQ helicase could provide a second approach to improve the therapy of patients with tumor-specific RECQ defects. [179] [180] [181] [182] These pathways have been identified in part by the recent gene expression-profiling experiments described above and could be further interrogated by focused RNA inhibition or drug/small-molecule screens.
Conclusion
Loss of function of three different members of the human RECQ helicase family, BLM, WRN, and RECQL4, leads to distinct diseases with developmental and acquired features including a markedly elevated risk of specific cancers. These "experiments of nature" have provided useful insights into the physiologic roles of the human RECQ helicases and how a loss of function leads to DNA metabolic defects together with adaptive changes that jointly drive disease pathogenesis.
